All New DNA Body Blueprint Provides Integrated Personal Action Plan Focusing on Genetic-Based Eating Behaviors, Nutrition and Metabolism
Simple, Effective and Secure At-Home DNA Test is Supported by Science and Comprehensively Developed to Help Weight Loss and Weight Management
FORT WASHINGTON, Pa.-Nutrisystem, Inc. (Nasdaq: NTRI), a leading provider of health and wellness and weight management products and services including Nutrisystem® and South Beach Diet® brands, today announced the launch of DNA Body Blueprint™, a genetic-based product using a proprietary algorithm that provides an integrated personal action plan focused on eating behaviors, nutrition and metabolism. The national marketing campaign will debut this week.
“By providing a personalized overview that is the ultimate roadmap for an individual’s ongoing nutritional needs, this product delivers on our mission of helping consumers make more informed choices and achieve outcomes that drive overall health,” commented Dawn Zier, President and CEO, Nutrisystem, Inc. “This groundbreaking use of DNA technology is a major step forward in the areas of weight loss, maintenance, and personalized nutrition. Consumer interest is high and we believe this product will attract new consumers to our brand as well as allow us to extend our relationship with them as they transition from weight loss to an ongoing healthy lifestyle.”
Years of Development Leads to National Debut
As a leader with a history in innovative and scientifically-backed weight loss solutions, Nutrisystem greenlighted the creation of DNA Body Blueprint based on a thorough assessment of market dynamics and scientific reviews from its Science Advisory Board. The board consists of a team of renowned professionals, each with distinct backgrounds and expertise, who helped evaluate existing research to enhance current programs, as well as develop new programs utilizing the latest science and technology trends within weight management.
“Nutrisystem, along with our Science Advisory Board, has had an eye on this space over the last few years and is pleased to see the technology safely and constructively evolve,” said David Burton, Executive Vice President of Operations at Nutrisystem, Inc. “Our mission is to match the most cutting-edge scientific developments with proven nutritional data to give our customers the best weight management experience possible, and we’re pleased to bring this to market after having worked extensively on this initiative for the last 24 months. We did an exhaustive search for the right partners and are proud to be rolling out a high-caliber offering at scale with unprecedented personalization.”
Dr. Tim Church, Medical Director, Genetic Direction, a distinguished researcher and specialist in public health and general preventive medicine and one of the country’s leading physicians in exercise and obesity research, echoed this sentiment, saying, “We’ve worked for many years to refine the science behind DNA testing as it relates to health and wellness. We now have a product that can make a difference in peoples’ lives and by working with Nutrisystem, together we can raise broad awareness and prompt mainstream adoption.”
Nutrisystem, through Genetic Direction, will be utilizing AKESOgen, an industry leading global genetic testing lab, to provide data and results using the most secure data encryption technology available, including de-identified samples and barcode matching.
Dr. Mark Bouzyk, Chief Scientific Officer, AKESOgen, who has been a global scientific leader in the precision genetics space over the last two decades commented, “The time is right to leverage the most robust and exciting scientific discoveries over the last several years in the public health and wellness continuum to benefit the community at large. This comes at a time of unprecedented cost benefits in genetic technologies that is coincidentally timely for the consumer market. Coupling this with Nutrisystem’s vision is absolutely a win-win for all.”
National Advertising & Marketing Campaign
DNA Body Blueprint is slated to be prominently featured in national multi-media marketing and advertising campaigns debuting today, July 16.
“We are thrilled to introduce our DNA-informed product nationwide, via television, social, paid digital, and eCRM. Our DNA Body Blueprint leverages what Nutrisystem does better than anyone. We start with cutting edge science, then make it simple and easy to understand. We’re excited to provide each customer with a blueprint to lose weight successfully. It’s the healthy eating approach designed by your body,” explained Keira Krausz, CMO, Nutrisystem, Inc. “We worked closely with potential customers to develop both the product and our campaign, and we know their ongoing insights will play a pivotal role in how we continue to evolve the offering.”
View one of the Body Blueprint DNA national television ads here.
The Science Behind Nutrisystem® DNA Body Blueprint™ White Paper can be found here.
Authors: LeeAnn Kindness, MS, Mandi Knowles, RDN/LDN, Courtney McCormick, MPH, RDN/LDN, Noah Voreades, MS, Mark Bouzyk, PhD, Dr. Mark Sarzynski
Reviewers: Gary Bennett, PhD., Ted Kyle, RPh, MBA
About Nutrisystem, Inc.
Nutrisystem, Inc. (Nasdaq: NTRI) is a leader in the weight-loss industry, having helped millions of people lose weight over the course of more than 45 years. The Company’s multi-brand approach to weight loss includes multiple plans for 2018. For more information, go to NutrisystemNews.com and Newsroom.SouthBeachDiet.com.
About Genetic Direction
Genetic Direction is a healthcare software company that improves individuals’ lives by evaluating key genetic markers and developing personalized health management programs in the areas of weight management, healthy aging and peak athletic performance. Genetic Direction’s proprietary algorithms and protocols utilize the latest peer-reviewed genetic research and are delivered to consumers, clients and patients through healthcare providers, retail marketing partners and directly via its secure web platform and one-on-one telehealth consultations.
AKESOgen is an integrated Clinical Laboratory Improvement Amendments (CLIA) compliant and the College of American Pathologists (CAP) accredited genomics, genetics and bio-banking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing, and research. Based in Atlanta, GA, USA, the company’s main focus is oncology, neurology and personalized medicine. AKESOgen’s services include providing high-throughput, biomarker profiling, cytogenetic arrays, sequencing, and genomics analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation). For more information, visit www.akesogen.com.
Robin McConnell Shallow
Senior Vice President, Corporate Communications and Public Relations
John Mills, Partner
Mark Bouzyk, Ph.D.
Chief Scientific Officer
770 542 0890